Global Heparin Market By Type (Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin), By Application (Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications), By Route of Administration (Subcutaneous and Intravenous), By End Use (Outpatient and Inpatient), By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Global Heparin Market size is expected to reach $10 billion by 2027, rising at a market growth of 6.5% CAGR during the forecast period. Heparin is also called unfractionated heparin (UFH). It refers to a glycosaminoglycan that naturally forms in the body. Heparin is widely used as an anticoagulant in medicine that acts as a blood thinner. Thus, it finds its application in the treatment of unstable angina and heart attacks. It can either injected into a vein or under the skin.

Acute coronary syndrome, pulmonary embolism, atrial fibrillation, deep vein thrombosis, cardiopulmonary bypass & hemofiltration during cardiac surgery can be treated by the use of heparin. Nowadays, it is also used in major orthopedic surgeries like hip and knee replacements.

As per the data published by the Centers for Disease Control and Prevention (CDC) in 2018, it is estimated that more than 900,000 people in the U.S. are suffering from pulmonary embolism and deep vein thrombosis every year. This factor is anticipated to boost the regional demand in the forecast period. The geriatric population is at greater risk of various chronic diseases like deep vein thrombosis and pulmonary embolism. The increasing incidences of chronic diseases will positively influence the expansion of the heparin market across the globe. Moreover, the introduction of highly precise and upgraded heparin products by the market players will boost the growth of the heparin market.

COVID-19 Impact Analysis

The sudden outbreak of COVID-19 has adversely affected the healthcare sector. It has disrupted workflows in the health care system all across the globe. Due to this viral disease, a number of industries were forced to shut their doors temporarily. It also includes several subdomains of health care. However, it has a positive effect on the heparin market as there is a surge in demand for various medical services. A large number of patients who are suffering from COVID-19, their lungs are severely affected as it is a respiratory disease. The demand for heparin has been increased during the pandemic as it is used to control respiratory inflation. It causes thinning of the blood and reduces the risk of a blood clot.

Anticoagulant medications also include low molecular weight heparins which are well-tolerated and they have fewer side effects. Irrespective of risk ratings, patients who get admitted to the hospital with COVID-19 infection are treated with prophylactic-dose of low molecular weight heparin. In the suspected COVID-19 infected patients, a baseline chest CT scan is performed and they are needed to be admitted to the hospital.

Various scientific studies revealed that the LMW heparin is capable of binding with SARS-CoV-2 Spike protein. So, it can be used as an effective therapeutic approach to reduce thrombosis and pulmonary embolism complications that arise in SARS-CoV-2 patients. As a result, heparin can be used in the treatment of COVID-19 patients. Though, various clinical studies & development are in progress to improve LMWH's efficacy.

Type Outlook

Based on Type, the market is segmented into Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin. There is no necessity for daily blood monitoring if treated with LMWH. All these factors are expected to boost the growth of the heparin market. Furthermore, according to a scientific study that was published in NEJM Journal Watch, the low occurrence of heparin-induced thrombocytopenia is expected to contribute towards the segment growth. Ultra-low molecular weight heparin is anticipated to be the fastest-growing segment in the coming years because of the commercialization of these products with enhanced pharmacological effects.

Application Outlook

Based on Application, the market is segmented into Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications. Venous thromboembolism (VTE) would witness fastest growth rate in the heparin market over the forecast years. Venous thromboembolism is of two types viz. pulmonary embolism (PE) and deep vein thrombosis (DVT). Due to increasing awareness about thrombosis, there is increased demand for heparin. It is one of the major factors boosting the segment growth.

Route of Administration Outlook

Based on Route of Administration, the market is segmented into Subcutaneous and Intravenous. The subcutaneous segment dominated the market in 2020. It would showcase the fastest growth rate and expected to see a lucrative CAGR over the forecast period due to less cost associated with hospitalization. Moreover, according to the patient’s perspective, the subcutaneous route is highly popular among the patients due to its ease of administration and increasing preference for home care, thus reducing the duration of treatment. Furthermore, other benefits of this route of administration comprise a lesser risk of systemic infection and better quality of life.

End Use Outlook

Based on End Use, the market is segmented into Outpatient and Inpatient. The outpatient segment garnered the maximum revenue share of the market in 2020 and expected to maintain its position over the forecast period. The preference for the subcutaneous route of administration has been increased among the patients. Thus, it is acting as a major factor contributing to the growth of the market.

Heparin Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 6.4 Billion
Market size forecast in 2027	USD 10 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 6.5% from 2021 to 2027
Number of Pages	239
Number of Tables	440
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Type, Application, Route of Administration, End Use, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increasing incidences of cardiovascular disease Increasing initiatives by the government to support R&D activities in drug development
Restraints	Adverse side effects of the heparin in some cases

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America dominated the heparin market in 2020. This is due to the rising cases of cardiovascular disorders in this region. Additionally, there is a higher level of healthcare expenditure, and increasing awareness among people which would boost the regional market. Another factor that is likely to drive the demand for heparin is the advanced healthcare infrastructure in this region.

Free Valuable Insights: Global Heparin Market size to reach USD 10 Billion by 2027

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer, Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, and Viatris, Inc.

Recent Strategies Deployed in Heparin Market

• Apr-2021: Fresenius Kabi unveiled two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex IV bags in the US. Heparin Sodium in Sodium Chloride injection is used as an anticoagulant to maintain catheter patency.
• Nov-2020: Fresenius Kabi came into partnership with Premier Inc. The partnership was aimed to supply pre-filled, single-use IV bags of heparin sodium injection, USP to healthcare providers, helping to stabilize the long-term supply of a medication that is necessary when performing a number of hospital inpatient procedures.
• Nov-2019: Fresenius Kabi introduced the preservative-free Heparin Sodium Injection in the US.
• Apr-2019: B. Braun Medical teamed up with Schreiner MediPharm, a global provider of specialty pharmaceutical labeling solutions. B. Braun recently introduced prefilled syringe of Heparin Sodium Injection, USP using Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
• Apr-2017: Fresenius Kabi signed an agreement to acquire Akorn, a manufacturer and marketer of prescription and over-the-counter pharmaceutical products. The acquisition would strengthen the capabilities of both the companies.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Low Molecular Weight Heparin
• Unfractionated Heparin
• Ultra-low Molecular Weight Heparin

By Application

• Atrial Fibrillation
• Coronary Artery Disease
• Venous Thromboembolism
• Renal Impairment
• Other Applications

By Route of Administration

• Subcutaneous
• Intravenous

By End Use

• Outpatient
• Inpatient

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Baxter International, Inc.
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Ltd.
• Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
• Dr. Reddy’s Laboratories Ltd.
• LEO Pharma A/S
• Viatris, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Heparin Market, by Type
1.4.2 Global Heparin Market, by Application
1.4.3 Global Heparin Market, by Route of Administration
1.4.4 Global Heparin Market, by End Use
1.4.5 Global Heparin Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Heparin Market by Type
3.1 Global Low Molecular Weight Heparin Market by Region
3.2 Global Unfractionated Heparin Market by Region
3.3 Global Ultra-low Molecular Weight Heparin Market by Region

Chapter 4. Global Heparin Market by Application
4.1 Global Atrial Fibrillation Market by Region
4.2 Global Coronary Artery Disease Market by Region
4.3 Global Venous Thromboembolism Market by Region
4.4 Global Renal Impairment Market by Region
4.5 Global Other Applications Market by Region

Chapter 5. Global Heparin Market by Route of Administration
5.1 Global Subcutaneous Market by Region
5.2 Global Intravenous Market by Region

Chapter 6. Global Heparin Market by End Use
6.1 Global Outpatient Market by Region
6.2 Global Inpatient Market by Region

Chapter 7. Global Heparin Market by Region
7.1 North America Heparin Market
7.1.1 North America Heparin Market by Type
7.1.1.1 North America Low Molecular Weight Heparin Market by Country
7.1.1.2 North America Unfractionated Heparin Market by Country
7.1.1.3 North America Ultra-low Molecular Weight Heparin Market by Country

Chapter 8. North America Heparin Market by Application
8.1.1.1 North America Atrial Fibrillation Market by Country
8.1.1.2 North America Coronary Artery Disease Market by Country
8.1.1.3 North America Venous Thromboembolism Market by Country
8.1.1.4 North America Renal Impairment Market by Country
8.1.1.5 North America Other Applications Market by Country
8.1.2 North America Heparin Market by Route of Administration
8.1.2.1 North America Subcutaneous Market by Region
8.1.2.2 North America Intravenous Market by Region
8.1.3 North America Heparin Market by End Use
8.1.3.1 North America Outpatient Market by Country
8.1.3.2 North America Inpatient Market by Country
8.1.4 North America Heparin Market by Region
8.1.4.1 US Heparin Market
8.1.4.1.1 US Heparin Market by Type
8.1.4.1.2 US Heparin Market by Application
8.1.4.1.3 US Unfractionated Heparin Market by Route of Administration
8.1.4.1.4 US Heparin Market by End Use
8.1.4.2 Canada Heparin Market
8.1.4.2.1 Canada Heparin Market by Type
8.1.4.2.2 Canada Heparin Market by Application
8.1.4.2.3 Canada Heparin Market by Route of Administration
8.1.4.2.4 Canada Heparin Market by End Use
8.1.4.3 Mexico Heparin Market
8.1.4.3.1 Mexico Heparin Market by Type
8.1.4.3.2 Mexico Heparin Market by Application
8.1.4.3.3 Mexico Unfractionated Heparin Market by Application
8.1.4.3.4 Mexico Heparin Market by Application
8.1.4.4 Rest of North America Heparin Market
8.1.4.4.1 Rest of North America Heparin Market by Type
8.1.4.4.2 Rest of North America Heparin Market by Application
8.1.4.4.3 Rest of North America Heparin Market by Route of Administration
8.1.4.4.4 Rest of North America Heparin Market by Application
8.2 Europe Heparin Market
8.2.1 Europe Heparin Market by Type
8.2.1.1 Europe Low Molecular Weight Heparin Market by Country
8.2.1.2 Europe Unfractionated Heparin Market by Country
8.2.1.3 Europe Ultra-low Molecular Weight Heparin Market by Country
8.2.2 Europe Heparin Market by Application
8.2.2.1 Europe Atrial Fibrillation Market by Country
8.2.2.2 Europe Coronary Artery Disease Market by Country
8.2.2.3 Europe Venous Thromboembolism Market by Country
8.2.2.4 Europe Renal Impairment Market by Country
8.2.2.5 Europe Other Applications Market by Country
8.2.3 Europe Heparin Market by Route of Administration
8.2.3.1 Europe Subcutaneous Market by Region
8.2.3.2 Europe Intravenous Market by Region
8.2.4 Europe Heparin Market by End Use
8.2.4.1 Europe Outpatient Market by Country
8.2.4.2 Europe Inpatient Market by Country
8.2.5 Europe Heparin Market by Region
8.2.5.1 Germany Heparin Market
8.2.5.1.1 Germany Heparin Market by Type
8.2.5.1.2 Germany Heparin Market by Application
8.2.5.1.3 Germany Heparin Market by Route of Administration
8.2.5.1.4 Germany Heparin Market by End Use
8.2.5.2 UK Heparin Market
8.2.5.2.1 UK Heparin Market by Type
8.2.5.2.2 UK Heparin Market by Application
8.2.5.2.3 UK Heparin Market by Route of Administration
8.2.5.2.4 UK Heparin Market by End Use
8.2.5.3 France Heparin Market
8.2.5.3.1 France Heparin Market by Type
8.2.5.3.2 France Heparin Market by Application
8.2.5.4 Russia Heparin Market
8.2.5.4.1 Russia Heparin Market by Type
8.2.5.4.2 Russia Heparin Market by Application
8.2.5.4.3 Russia Heparin Market by Route of Administration
8.2.5.4.4 Russia Heparin Market by End Use
8.2.5.5 Spain Heparin Market
8.2.5.5.1 Spain Heparin Market by Type
8.2.5.5.2 Spain Heparin Market by Application
8.2.5.5.3 Spain Heparin Market by Route of Administration
8.2.5.5.4 Spain Heparin Market by End Use
8.2.5.6 Italy Heparin Market
8.2.5.6.1 Italy Heparin Market by Type
8.2.5.6.2 Italy Heparin Market by Application
8.2.5.6.3 Italy Heparin Market by Route of Administration
8.2.5.7 Rest of Europe Heparin Market
8.2.5.7.1 Rest of Europe Heparin Market by Type
8.2.5.7.2 Rest of Europe Heparin Market by Application
8.2.5.7.3 Rest of Europe Heparin Market by Route of Administration
8.2.5.7.4 Rest of Europe Heparin Market by End Use
8.3 Asia Pacific Heparin Market
8.3.1 Asia Pacific Heparin Market by Type
8.3.1.1 Asia Pacific Low Molecular Weight Heparin Market by Country
8.3.1.2 Asia Pacific Unfractionated Heparin Market by Country
8.3.1.3 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country
8.3.2 Asia Pacific Heparin Market by Application
8.3.2.1 Asia Pacific Atrial Fibrillation Market by Country
8.3.2.2 Asia Pacific Coronary Artery Disease Market by Country
8.3.2.3 Asia Pacific Venous Thromboembolism Market by Country
8.3.2.4 Asia Pacific Renal Impairment Market by Country
8.3.2.5 Asia Pacific Other Applications Market by Country
8.3.3 Asia Pacific Heparin Market by Route of Administration
8.3.3.1 Asia Pacific Subcutaneous Market by Region
8.3.3.2 Asia Pacific Intravenous Market by Region
8.3.4 Asia Pacific Heparin Market by End Use
8.3.4.1 Asia Pacific Outpatient Market by Country
8.3.4.2 Asia Pacific Inpatient Market by Country
8.3.5 Asia Pacific Heparin Market by Region
8.3.5.1 China Heparin Market
8.3.5.1.1 China Heparin Market by Type
8.3.5.1.2 China Heparin Market by Application
8.3.5.1.3 China Heparin Market by Route of Administration
8.3.5.1.4 China Heparin Market by End Use
8.3.5.2 Japan Heparin Market
8.3.5.2.1 Japan Heparin Market by Type
8.3.5.2.2 Japan Heparin Market by Application
8.3.5.2.3 Japan Heparin Market by Route of Administration
8.3.5.2.4 Japan Heparin Market by End Use
8.3.5.3 India Heparin Market
8.3.5.3.1 India Heparin Market by Type
8.3.5.3.2 India Heparin Market by Application
8.3.5.3.3 India Heparin Market by Route of Administration
8.3.5.3.4 India Heparin Market by End Use
8.3.5.4 South Korea Heparin Market
8.3.5.4.1 South Korea Heparin Market by Type
8.3.5.4.2 South Korea Heparin Market by Application
8.3.5.4.3 South Korea Heparin Market by Route of Administration
8.3.5.4.4 South Korea Heparin Market by End Use
8.3.5.5 Singapore Heparin Market
8.3.5.5.1 Singapore Heparin Market by Type
8.3.5.5.2 Singapore Heparin Market by Application
8.3.5.5.3 Singapore Heparin Market by Route of Administration
8.3.5.5.4 Singapore Heparin Market by End Use
8.3.5.6 Malaysia Heparin Market
8.3.5.6.1 Malaysia Heparin Market by Type
8.3.5.6.2 Malaysia Heparin Market by Application
8.3.5.6.3 Malaysia Heparin Market by Route of Administration
8.3.5.6.4 Malaysia Heparin Market by End Use
8.3.5.7 Rest of Asia Pacific Heparin Market
8.3.5.7.1 Rest of Asia Pacific Heparin Market by Type
8.3.5.7.2 Rest of Asia Pacific Heparin Market by Application
8.3.5.7.3 Rest of Asia Pacific Heparin Market by Route of Administration
8.3.5.7.4 Rest of Asia Heparin Market by End Use
8.4 LAMEA Heparin Market
8.4.1 LAMEA Heparin Market by Type
8.4.1.1 LAMEA Low Molecular Weight Heparin Market by Country
8.4.1.2 LAMEA Unfractionated Heparin Market by Country
8.4.1.3 LAMEA Ultra-low Molecular Weight Heparin Market by Country
8.4.2 LAMEA Heparin Market by Application
8.4.2.1 LAMEA Atrial Fibrillation Market by Country
8.4.2.2 LAMEA Coronary Artery Disease Market by Country
8.4.2.3 LAMEA Venous Thromboembolism Market by Country
8.4.2.4 LAMEA Renal Impairment Market by Country
8.4.2.5 LAMEA Other Applications Market by Country
8.4.3 LAMEA Heparin Market by Route of Administration
8.4.3.1 LAMEA Subcutaneous Market by Region
8.4.3.2 LAMEA Intravenous Market by Region
8.4.4 LAMEA Heparin Market by End Use
8.4.4.1 LAMEA Outpatient Market by Country
8.4.4.2 LAMEA Inpatient Market by Country
8.4.5 LAMEA Heparin Market by Region
8.4.5.1 Brazil Heparin Market
8.4.5.1.1 Brazil Heparin Market by Type
8.4.5.1.2 Brazil Heparin Market by Application
8.4.5.1.3 Brazil Heparin Market by Route of Administration
8.4.5.1.4 Brazil Heparin Market by End Use
8.4.5.2 Argentina Heparin Market
8.4.5.2.1 Argentina Heparin Market by Type
8.4.5.2.2 Argentina Heparin Market by Application
8.4.5.3 Argentina Heparin Market by Route of Administration
8.4.5.3.1 Argentina Heparin Market by End Use
8.4.5.4 UAE Heparin Market
8.4.5.4.1 UAE Heparin Market by Type
8.4.5.4.2 UAE Heparin Market by Application
8.4.5.4.3 UAE Unfractionated Heparin Market by Route of Administration
8.4.5.4.4 UAE Heparin Market by End Use
8.4.5.5 Saudi Arabia Heparin Market
8.4.5.5.1 Saudi Arabia Heparin Market by Type
8.4.5.5.2 Saudi Arabia Heparin Market by Application
8.4.5.5.3 Saudi Arabia Heparin Market by Route of Administration
8.4.5.5.4 Saudi Arabia Heparin Market by End Use
8.4.5.6 South Africa Heparin Market
8.4.5.6.1 South Africa Heparin Market by Type
8.4.5.6.2 South Africa Heparin Market by Application
8.4.5.6.3 South Africa Heparin Market by Route of Administration
8.4.5.6.4 South Africa Heparin Market by End Use
8.4.5.7 Nigeria Heparin Market
8.4.5.7.1 Nigeria Heparin Market by Type
8.4.5.7.2 Nigeria Heparin Market by Application
8.4.5.7.3 Nigeria Heparin Market by Route of Administration
8.4.5.7.4 Nigeria Heparin Market by End Use
8.4.5.8 Rest of LAMEA Heparin Market
8.4.5.8.1 Rest of LAMEA Heparin Market by Type
8.4.5.8.2 Rest of LAMEA Heparin Market by Application
8.4.5.9 Rest of LAMEA Heparin Market by Route of Administration
8.4.5.9.1 Rest of LAMEA Heparin Market by End Use

Chapter 9. Company Profiles
9.1 Baxter International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.2 B. Braun Melsungen AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 Fresenius SE & Co. KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.1 Recent strategies and developments:
9.3.1.1 Partnerships, Collaborations, and Agreements:
9.3.1.2 Acquisition and Mergers:
9.3.1.3 Product Launches and Product Expansions:
9.4 Pfizer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.5 Sanofi S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Teva Pharmaceutical Industries Ltd.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.7 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
9.7.1 Company Overview
9.8 Dr. Reddy’s Laboratories Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 LEO Pharma A/S
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.10. Viatris, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense

TABLE 1 Global Heparin Market, 2017 - 2020, USD Million
TABLE 2 Global Heparin Market, 2021 - 2027, USD Million
TABLE 3 Global Heparin Market by Type, 2017 - 2020, USD Million
TABLE 4 Global Heparin Market by Type, 2021 - 2027, USD Million
TABLE 5 Global Low Molecular Weight Heparin Market by Region, 2017 - 2020, USD Million
TABLE 6 Global Low Molecular Weight Heparin Market by Region, 2021 - 2027, USD Million
TABLE 7 Global Unfractionated Heparin Market by Region, 2017 - 2020, USD Million
TABLE 8 Global Unfractionated Heparin Market by Region, 2021 - 2027, USD Million
TABLE 9 Global Ultra-low Molecular Weight Heparin Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Ultra-low Molecular Weight Heparin Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Heparin Market by Application, 2017 - 2020, USD Million
TABLE 12 Global Heparin Market by Application, 2021 - 2027, USD Million
TABLE 13 Global Atrial Fibrillation Market by Region, 2017 - 2020, USD Million
TABLE 14 Global Atrial Fibrillation Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Coronary Artery Disease Market by Region, 2017 - 2020, USD Million
TABLE 16 Global Coronary Artery Disease Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Venous Thromboembolism Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Venous Thromboembolism Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Renal Impairment Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Renal Impairment Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Other Applications Market by Region, 2017 - 2020, USD Million
TABLE 22 Global Other Applications Market by Region, 2021 - 2027, USD Million
TABLE 23 Global Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 24 Global Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 25 Global Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 29 Global Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 30 Global Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 31 Global Outpatient Market by Region, 2017 - 2020, USD Million
TABLE 32 Global Outpatient Market by Region, 2021 - 2027, USD Million
TABLE 33 Global Inpatient Market by Region, 2017 - 2020, USD Million
TABLE 34 Global Inpatient Market by Region, 2021 - 2027, USD Million
TABLE 35 Global Heparin Market by Region, 2017 - 2020, USD Million
TABLE 36 Global Heparin Market by Region, 2021 - 2027, USD Million
TABLE 37 North America Heparin Market, 2017 - 2020, USD Million
TABLE 38 North America Heparin Market, 2021 - 2027, USD Million
TABLE 39 North America Heparin Market by Type, 2017 - 2020, USD Million
TABLE 40 North America Heparin Market by Type, 2021 - 2027, USD Million
TABLE 41 North America Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 42 North America Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 43 North America Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 44 North America Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 46 North America Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 47 North America Heparin Market by Application, 2017 - 2020, USD Million
TABLE 48 North America Heparin Market by Application, 2021 - 2027, USD Million
TABLE 49 North America Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 54 North America Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 55 North America Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 57 North America Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 58 North America Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 59 North America Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 60 North America Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 61 North America Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 62 North America Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 63 North America Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 64 North America Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 65 North America Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 66 North America Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 67 North America Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 68 North America Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 69 North America Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 70 North America Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 71 North America Heparin Market by Region, 2017 - 2020, USD Million
TABLE 72 North America Heparin Market by Region, 2021 - 2027, USD Million
TABLE 73 US Heparin Market, 2017 - 2020, USD Million
TABLE 74 US Heparin Market, 2021 - 2027, USD Million
TABLE 75 US Heparin Market by Type, 2017 - 2020, USD Million
TABLE 76 US Heparin Market by Type, 2021 - 2027, USD Million
TABLE 77 US Heparin Market by Application, 2017 - 2020, USD Million
TABLE 78 US Heparin Market by Application, 2021 - 2027, USD Million
TABLE 79 US Unfractionated Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 80 US Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 81 US Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 82 US Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 83 Canada Heparin Market, 2017 - 2020, USD Million
TABLE 84 Canada Heparin Market, 2021 - 2027, USD Million
TABLE 85 Canada Heparin Market by Type, 2017 - 2020, USD Million
TABLE 86 Canada Heparin Market by Type, 2021 - 2027, USD Million
TABLE 87 Canada Heparin Market by Application, 2017 - 2020, USD Million
TABLE 88 Canada Heparin Market by Application, 2021 - 2027, USD Million
TABLE 89 Canada Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 90 Canada Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 91 Canada Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 92 Canada Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 93 Mexico Heparin Market, 2017 - 2020, USD Million
TABLE 94 Mexico Heparin Market, 2021 - 2027, USD Million
TABLE 95 Mexico Heparin Market by Type, 2017 - 2020, USD Million
TABLE 96 Mexico Heparin Market by Type, 2021 - 2027, USD Million
TABLE 97 Mexico Heparin Market by Application, 2017 - 2020, USD Million
TABLE 98 Mexico Heparin Market by Application, 2021 - 2027, USD Million
TABLE 99 Mexico Unfractionated Heparin Market by Application, 2017 - 2020, USD Million
TABLE 100 Mexico Unfractionated Heparin Market by Application, 2021 - 2027, USD Million
TABLE 101 Mexico Heparin Market by Application, 2017 - 2020, USD Million
TABLE 102 Mexico Heparin Market by Application, 2021 - 2027, USD Million
TABLE 103 Rest of North America Heparin Market, 2017 - 2020, USD Million
TABLE 104 Rest of North America Heparin Market, 2021 - 2027, USD Million
TABLE 105 Rest of North America Heparin Market by Type, 2017 - 2020, USD Million
TABLE 106 Rest of North America Heparin Market by Type, 2021 - 2027, USD Million
TABLE 107 Rest of North America Heparin Market by Application, 2017 - 2020, USD Million
TABLE 108 Rest of North America Heparin Market by Application, 2021 - 2027, USD Million
TABLE 109 Rest of North America Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 110 Rest of North America Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 111 Rest of North America Ultra-Heparin Market by Application, 2017 - 2020, USD Million
TABLE 112 Rest of North America Ultra-Heparin Market by Application, 2021 - 2027, USD Million
TABLE 113 Europe Heparin Market, 2017 - 2020, USD Million
TABLE 114 Europe Heparin Market, 2021 - 2027, USD Million
TABLE 115 Europe Heparin Market by Type, 2017 - 2020, USD Million
TABLE 116 Europe Heparin Market by Type, 2021 - 2027, USD Million
TABLE 117 Europe Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 118 Europe Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 119 Europe Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 120 Europe Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 121 Europe Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 122 Europe Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 123 Europe Heparin Market by Application, 2017 - 2020, USD Million
TABLE 124 Europe Heparin Market by Application, 2021 - 2027, USD Million
TABLE 125 Europe Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 126 Europe Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 127 Europe Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 128 Europe Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 129 Europe Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 130 Europe Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 131 Europe Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 132 Europe Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 133 Europe Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 134 Europe Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 135 Europe Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 136 Europe Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 137 Europe Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 138 Europe Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 139 Europe Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 140 Europe Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 141 Europe Heparin Market by End use, 2017 - 2020, USD Million
TABLE 142 Europe Heparin Market by End USe, 2021 - 2027, USD Million
TABLE 143 Europe Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 144 Europe Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 145 Europe Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 146 Europe Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 147 Europe Heparin Market by Region, 2017 - 2020, USD Million
TABLE 148 Europe Heparin Market by Region, 2021 - 2027, USD Million
TABLE 149 Germany Heparin Market, 2017 - 2020, USD Million
TABLE 150 Germany Heparin Market, 2021 - 2027, USD Million
TABLE 151 Germany Heparin Market by Type, 2017 - 2020, USD Million
TABLE 152 Germany Heparin Market by Type, 2021 - 2027, USD Million
TABLE 153 Germany Heparin Market by Application, 2017 - 2020, USD Million
TABLE 154 Germany Heparin Market by Application, 2021 - 2027, USD Million
TABLE 155 Germany Heparin Market by route of Administration, 2017 - 2020, USD Million
TABLE 156 Germany Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 157 Germany Heparin Market by End USE, 2017 - 2020, USD Million
TABLE 158 Germany Ultra-Heparin Market by end Use, 2021 - 2027, USD Million
TABLE 159 UK Heparin Market, 2017 - 2020, USD Million
TABLE 160 UK Heparin Market, 2021 - 2027, USD Million
TABLE 161 UK Heparin Market by Type, 2017 - 2020, USD Million
TABLE 162 UK Heparin Market by Type, 2021 - 2027, USD Million
TABLE 163 UK Heparin Market by Application, 2017 - 2020, USD Million
TABLE 164 UK Heparin Market by Application, 2021 - 2027, USD Million
TABLE 165 UK Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 166 UK Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 167 UK Heparin Market by end use, 2017 - 2020, USD Million
TABLE 168 UK Heparin Market by Application, 2021 - 2027, USD Million
TABLE 169 France Heparin Market, 2017 - 2020, USD Million
TABLE 170 France Heparin Market, 2021 - 2027, USD Million
TABLE 171 France Heparin Market by Type, 2017 - 2020, USD Million
TABLE 172 France Heparin Market by Type, 2021 - 2027, USD Million
TABLE 173 France Heparin Market by Application, 2017 - 2020, USD Million
TABLE 174 France Heparin Market by Application, 2021 - 2027, USD Million
TABLE 175 France Heparin Market by Route of administration, 2017 - 2020, USD Million
TABLE 176 France Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 177 France Heparin Market by end use, 2017 - 2020, USD Million
TABLE 178 France Heparin Market by END USE, 2021 - 2027, USD Million
TABLE 179 Russia Heparin Market, 2017 - 2020, USD Million
TABLE 180 Russia Heparin Market, 2021 - 2027, USD Million
TABLE 181 Russia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 182 Russia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 183 Russia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 184 Russia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 185 Russia Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 186 Russia Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 187 Russia Heparin Market by End USe, 2017 - 2020, USD Million
TABLE 188 Russia Ultra-Heparin Market by end use, 2021 - 2027, USD Million
TABLE 189 Spain Heparin Market, 2017 - 2020, USD Million
TABLE 190 Spain Heparin Market, 2021 - 2027, USD Million
TABLE 191 Spain Heparin Market by Type, 2017 - 2020, USD Million
TABLE 192 Spain Heparin Market by Type, 2021 - 2027, USD Million
TABLE 193 Spain Heparin Market by Application, 2017 - 2020, USD Million
TABLE 194 Spain Heparin Market by Application, 2021 - 2027, USD Million
TABLE 195 Spain Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 196 Spain Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 197 Spain Heparin Market by End use, 2017 - 2020, USD Million
TABLE 198 Spain Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 199 Italy Heparin Market, 2017 - 2020, USD Million
TABLE 200 Italy Heparin Market, 2021 - 2027, USD Million
TABLE 201 Italy Heparin Market by Type, 2017 - 2020, USD Million
TABLE 202 Italy Heparin Market by Type, 2021 - 2027, USD Million
TABLE 203 Italy Heparin Market by Application, 2017 - 2020, USD Million
TABLE 204 Italy Heparin Market by Application, 2021 - 2027, USD Million
TABLE 205 Italy Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 206 Italy Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 207 Italy Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 208 Italy Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 209 Rest of Europe Heparin Market, 2017 - 2020, USD Million
TABLE 210 Rest of Europe Heparin Market, 2021 - 2027, USD Million
TABLE 211 Rest of Europe Heparin Market by Type, 2017 - 2020, USD Million
TABLE 212 Rest of Europe Heparin Market by Type, 2021 - 2027, USD Million
TABLE 213 Rest of Europe Heparin Market by Application, 2017 - 2020, USD Million
TABLE 214 Rest of Europe Heparin Market by Application, 2021 - 2027, USD Million
TABLE 215 Rest of Europe Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 216 Rest of Europe Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 217 Rest of Europe Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 218 Rest of Europe Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 219 Asia Pacific Heparin Market, 2017 - 2020, USD Million
TABLE 220 Asia Pacific Heparin Market, 2021 - 2027, USD Million
TABLE 221 Asia Pacific Heparin Market by Type, 2017 - 2020, USD Million
TABLE 222 Asia Pacific Heparin Market by Type, 2021 - 2027, USD Million
TABLE 223 Asia Pacific Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 224 Asia Pacific Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 225 Asia Pacific Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 226 Asia Pacific Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 227 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 228 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 229 Asia Pacific Heparin Market by Application, 2017 - 2020, USD Million
TABLE 230 Asia Pacific Heparin Market by Application, 2021 - 2027, USD Million
TABLE 231 Asia Pacific Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 232 Asia Pacific Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 233 Asia Pacific Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 234 Asia Pacific Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 235 Asia Pacific Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 236 Asia Pacific Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 237 Asia Pacific Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 238 Asia Pacific Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 239 Asia Pacific Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 240 Asia Pacific Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 241 Asia Pacific Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 242 Asia Pacific Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 243 Asia Pacific Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 244 Asia Pacific Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 245 Asia Pacific Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 246 Asia Pacific Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 247 Asia Pacific Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 248 Asia Pacific Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 249 Asia Pacific Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 250 Asia Pacific Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 251 Asia Pacific Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 252 Asia Pacific Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 253 Asia Pacific Heparin Market by Region, 2017 - 2020, USD Million
TABLE 254 Asia Pacific Heparin Market by Region, 2021 - 2027, USD Million
TABLE 255 China Heparin Market, 2017 - 2020, USD Million
TABLE 256 China Heparin Market, 2021 - 2027, USD Million
TABLE 257 China Heparin Market by Type, 2017 - 2020, USD Million
TABLE 258 China Heparin Market by Type, 2021 - 2027, USD Million
TABLE 259 China Heparin Market by Application, 2017 - 2020, USD Million
TABLE 260 China Heparin Market by Application, 2021 - 2027, USD Million
TABLE 261 China Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 262 China Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 263 China Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 264 China Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 265 Japan Heparin Market, 2017 - 2020, USD Million
TABLE 266 Japan Heparin Market, 2021 - 2027, USD Million
TABLE 267 Japan Heparin Market by Type, 2017 - 2020, USD Million
TABLE 268 Japan Heparin Market by Type, 2021 - 2027, USD Million
TABLE 269 Japan Heparin Market by Application, 2017 - 2020, USD Million
TABLE 270 Japan Heparin Market by Application, 2021 - 2027, USD Million
TABLE 271 Japan Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 272 Japan Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 273 Japan Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 274 Japan Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 275 India Heparin Market, 2017 - 2020, USD Million
TABLE 276 India Heparin Market, 2021 - 2027, USD Million
TABLE 277 India Heparin Market by Type, 2017 - 2020, USD Million
TABLE 278 India Heparin Market by Type, 2021 - 2027, USD Million
TABLE 279 India Heparin Market by Application, 2017 - 2020, USD Million
TABLE 280 India Heparin Market by Application, 2021 - 2027, USD Million
TABLE 281 India Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 282 India Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 283 India Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 284 India Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 285 South Korea Heparin Market, 2017 - 2020, USD Million
TABLE 286 South Korea Heparin Market, 2021 - 2027, USD Million
TABLE 287 South Korea Heparin Market by Type, 2017 - 2020, USD Million
TABLE 288 South Korea Heparin Market by Type, 2021 - 2027, USD Million
TABLE 289 South Korea Heparin Market by Application, 2017 - 2020, USD Million
TABLE 290 South Korea Heparin Market by Application, 2021 - 2027, USD Million
TABLE 291 South Korea Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 292 South Korea Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 293 South Korea Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 294 South Korea Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 295 Singapore Heparin Market, 2017 - 2020, USD Million
TABLE 296 Singapore Heparin Market, 2021 - 2027, USD Million
TABLE 297 Singapore Heparin Market by Type, 2017 - 2020, USD Million
TABLE 298 Singapore Heparin Market by Type, 2021 - 2027, USD Million
TABLE 299 Singapore Heparin Market by Application, 2017 - 2020, USD Million
TABLE 300 Singapore Heparin Market by Application, 2021 - 2027, USD Million
TABLE 301 Singapore Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 302 Singapore Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 303 Singapore Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 304 Singapore Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 305 Malaysia Heparin Market, 2017 - 2020, USD Million
TABLE 306 Malaysia Heparin Market, 2021 - 2027, USD Million
TABLE 307 Malaysia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 308 Malaysia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 309 Malaysia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 310 Malaysia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 311 Malaysia Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 312 Malaysia Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 313 Malaysia Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 314 Malaysia Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 315 Rest of Asia Pacific Heparin Market, 2017 - 2020, USD Million
TABLE 316 Rest of Asia Pacific Heparin Market, 2021 - 2027, USD Million
TABLE 317 Rest of Asia Pacific Heparin Market by Type, 2017 - 2020, USD Million
TABLE 318 Rest of Asia Pacific Heparin Market by Type, 2021 - 2027, USD Million
TABLE 319 Rest of Asia Pacific Heparin Market by Application, 2017 - 2020, USD Million
TABLE 320 Rest of Asia Pacific Heparin Market by Application, 2021 - 2027, USD Million
TABLE 321 Rest of Asia Pacific Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 322 Rest of Asia Pacific Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 323 Rest of Asia Pacific Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 324 Rest of Asia Pacific Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 325 LAMEA Heparin Market, 2017 - 2020, USD Million
TABLE 326 LAMEA Heparin Market, 2021 - 2027, USD Million
TABLE 327 LAMEA Heparin Market by Type, 2017 - 2020, USD Million
TABLE 328 LAMEA Heparin Market by Type, 2021 - 2027, USD Million
TABLE 329 LAMEA Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 330 LAMEA Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 331 LAMEA Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 332 LAMEA Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 333 LAMEA Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 334 LAMEA Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 335 LAMEA Heparin Market by Application, 2017 - 2020, USD Million
TABLE 336 LAMEA Heparin Market by Application, 2021 - 2027, USD Million
TABLE 337 LAMEA Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 338 LAMEA Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 339 LAMEA Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 340 LAMEA Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 341 LAMEA Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 342 LAMEA Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 343 LAMEA Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 344 LAMEA Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 345 LAMEA Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 346 LAMEA Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 347 LAMEA Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 348 LAMEA Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 349 LAMEA Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 350 LAMEA Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 351 LAMEA Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 352 LAMEA Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 353 LAMEA Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 354 LAMEA Heparin Market by End USe, 2021 - 2027, USD Million
TABLE 355 LAMEA Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 356 LAMEA Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 357 LAMEA Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 358 LAMEA Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 359 LAMEA Heparin Market by Region, 2017 - 2020, USD Million
TABLE 360 LAMEA Heparin Market by Region, 2021 - 2027, USD Million
TABLE 361 Brazil Heparin Market, 2017 - 2020, USD Million
TABLE 362 Brazil Heparin Market, 2021 - 2027, USD Million
TABLE 363 Brazil Heparin Market by Type, 2017 - 2020, USD Million
TABLE 364 Brazil Heparin Market by Type, 2021 - 2027, USD Million
TABLE 365 Brazil Heparin Market by Application, 2017 - 2020, USD Million
TABLE 366 Brazil Heparin Market by Application, 2021 - 2027, USD Million
TABLE 367 Brazil Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 368 Brazil Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 369 Brazil Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 370 Brazil Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 371 Argentina Heparin Market, 2017 - 2020, USD Million
TABLE 372 Argentina Heparin Market, 2021 - 2027, USD Million
TABLE 373 Argentina Heparin Market by Type, 2017 - 2020, USD Million
TABLE 374 Argentina Heparin Market by Type, 2021 - 2027, USD Million
TABLE 375 Argentina Heparin Market by Application, 2017 - 2020, USD Million
TABLE 376 Argentina Heparin Market by Application, 2021 - 2027, USD Million
TABLE 377 Argentina Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 378 Argentina Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 379 Argentina Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 380 Argentina Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 381 UAE Heparin Market, 2017 - 2020, USD Million
TABLE 382 UAE Heparin Market, 2021 - 2027, USD Million
TABLE 383 UAE Heparin Market by Type, 2017 - 2020, USD Million
TABLE 384 UAE Heparin Market by Type, 2021 - 2027, USD Million
TABLE 385 UAE Heparin Market by Application, 2017 - 2020, USD Million
TABLE 386 UAE Heparin Market by Application, 2021 - 2027, USD Million
TABLE 387 UAE Unfractionated Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 388 UAE Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 389 UAE Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 390 UAE Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 391 Saudi Arabia Heparin Market, 2017 - 2020, USD Million
TABLE 392 Saudi Arabia Heparin Market, 2021 - 2027, USD Million
TABLE 393 Saudi Arabia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 394 Saudi Arabia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 395 Saudi Arabia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 396 Saudi Arabia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 397 Saudi Arabia Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 398 Saudi Arabia Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 399 Saudi Arabia Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 400 Saudi Arabia Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 401 South Africa Heparin Market, 2017 - 2020, USD Million
TABLE 402 South Africa Heparin Market, 2021 - 2027, USD Million
TABLE 403 South Africa Heparin Market by Type, 2017 - 2020, USD Million
TABLE 404 South Africa Heparin Market by Type, 2021 - 2027, USD Million
TABLE 405 South Africa Heparin Market by Application, 2017 - 2020, USD Million
TABLE 406 South Africa Heparin Market by Application, 2021 - 2027, USD Million
TABLE 407 South Africa Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 408 South Africa Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 409 South Africa Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 410 South Africa Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 411 Nigeria Heparin Market, 2017 - 2020, USD Million
TABLE 412 Nigeria Heparin Market, 2021 - 2027, USD Million
TABLE 413 Nigeria Heparin Market by Type, 2017 - 2020, USD Million
TABLE 414 Nigeria Heparin Market by Type, 2021 - 2027, USD Million
TABLE 415 Nigeria Heparin Market by Application, 2017 - 2020, USD Million
TABLE 416 Nigeria Heparin Market by Application, 2021 - 2027, USD Million
TABLE 417 Nigeria Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 418 Nigeria Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 419 Nigeria Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 420 Nigeria Ultra-Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 421 Rest of LAMEA Heparin Market, 2017 - 2020, USD Million
TABLE 422 Rest of LAMEA Heparin Market, 2021 - 2027, USD Million
TABLE 423 Rest of LAMEA Heparin Market by Type, 2017 - 2020, USD Million
TABLE 424 Rest of LAMEA Heparin Market by Type, 2021 - 2027, USD Million
TABLE 425 Rest of LAMEA Heparin Market by Application, 2017 - 2020, USD Million
TABLE 426 Rest of LAMEA Heparin Market by Application, 2021 - 2027, USD Million
TABLE 427 Rest of LAMEA Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 428 Rest of LAMEA Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 429 Rest of LAMEA Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 430 Rest of LAMEA Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 431 Key Information – Baxter International, Inc.
TABLE 432 key Information – B. Braun Melsungen AG
TABLE 433 key information – Fresenius SE & Co. KGaA
TABLE 434 Key Information – Pfizer, Inc.
TABLE 435 Key Information – Sanofi S.A.
TABLE 436 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 437 key information – Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
TABLE 438 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 439 key information – LEO Pharma A/S
TABLE 440 key information – Viatris, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Fresenius SE & Co. KGaA